Open AccessEffectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis
Author(s) -
Juan José Alegre-Sancho,
Xavier Juanola,
José Manuel Rodríguez-Heredia,
Javier Manero,
Ignacio Villa-Blanco,
A. Laíz,
María Jesús Soler Arteaga,
Luis CeaCalvo,
Carlos González-Fernández
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000025223
Subject(s) - golimumab , medicine , psoriatic arthritis , etanercept , adalimumab , proportional hazards model , ankylosing spondylitis , discontinuation , rheumatology , retrospective cohort study , secukinumab , arthritis , surgery , rheumatoid arthritis